Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Kiora Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:KPRX | Benzinga
Kiora Pharmaceuticals Inc has a consensus price target of $43.67 based on the ratings of 3 analysts. The high is $119 issued by Ladenburg Thalmann on February 8, 2023. The low is $2 issued by Maxim Group on August 9, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 28, 2025, November 12, 2024, and August 22, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 203.23% upside for Kiora Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Kiora Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/28/2025 | Buy Now | 203.23% | HC Wainwright & Co. | Yi Chen59% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 203.23% | HC Wainwright & Co. | Yi Chen59% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2024 | Buy Now | 203.23% | HC Wainwright & Co. | Yi Chen59% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 07/23/2024 | Buy Now | 203.23% | HC Wainwright & Co. | Yi Chen59% | $2 → $10 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | -39.35% | HC Wainwright & Co. | Yi Chen59% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | -39.35% | HC Wainwright & Co. | Yi Chen59% | $2 → $2 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -39.35% | HC Wainwright & Co. | Yi Chen59% | $3.5 → $2 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 6.13% | HC Wainwright & Co. | Yi Chen59% | → $3.5 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | Buy Now | 6.13% | HC Wainwright & Co. | Yi Chen59% | $2 → $3.5 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | -39.35% | HC Wainwright & Co. | Yi Chen59% | → $2 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | -39.35% | HC Wainwright & Co. | Yi Chen59% | $7 → $2 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -39.35% | Maxim Group | Michael Okunewitch15% | $12 → $2 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | 112.26% | HC Wainwright & Co. | Yi Chen59% | $6 → $7 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | 81.94% | HC Wainwright & Co. | Yi Chen59% | $10 → $6 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | Buy Now | 263.88% | Maxim Group | Michael Okunewitch15% | → $12 | Upgrade | Hold → Buy | Get Alert |
| 02/08/2023 | Buy Now | 203.23% | HC Wainwright & Co. | Yi Chen59% | → $10 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 3508.47% | Ladenburg Thalmann | Matthew Kaplan69% | → $119 | Reiterates | → Buy | Get Alert |
| 08/25/2022 | Buy Now | 97.1% | Ladenburg Thalmann | Matthew Kaplan69% | → $6.5 | Initiates | → Buy | Get Alert |
| 08/15/2022 | Buy Now | — | Maxim Group | Michael Okunewitch15% | — | Downgrade | Buy → Hold | Get Alert |
| 07/11/2022 | Buy Now | -24.19% | HC Wainwright & Co. | Yi Chen59% | $3 → $2.5 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Kiora Pharmaceuticals (KPRX) stock?
The latest price target for Kiora Pharmaceuticals (NASDAQ:KPRX) was reported by HC Wainwright & Co. on March 28, 2025. The analyst firm set a price target for $10.00 expecting KPRX to rise to within 12 months (a possible 203.23% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kiora Pharmaceuticals (KPRX)?
The latest analyst rating for Kiora Pharmaceuticals (NASDAQ:KPRX) was provided by HC Wainwright & Co., and Kiora Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Kiora Pharmaceuticals (KPRX)?
The last upgrade for Kiora Pharmaceuticals Inc happened on February 9, 2023 when Maxim Group raised their price target to $12. Maxim Group previously had a hold for Kiora Pharmaceuticals Inc.
When was the last downgrade for Kiora Pharmaceuticals (KPRX)?
The last downgrade for Kiora Pharmaceuticals Inc happened on August 15, 2022 when Maxim Group changed their price target from N/A to N/A for Kiora Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Kiora Pharmaceuticals (KPRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiora Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiora Pharmaceuticals was filed on March 28, 2025 so you should expect the next rating to be made available sometime around March 28, 2026.
Is the Analyst Rating Kiora Pharmaceuticals (KPRX) correct?
While ratings are subjective and will change, the latest Kiora Pharmaceuticals (KPRX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Kiora Pharmaceuticals (KPRX) is trading at is $3.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
